References
Sullivan KM, Parkman R, Walters MC. Bone marrow tansplantation for non-malignant disease.Hematology (Am Soc Hematol Educ Prog). 2000;2000:319–338.
Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency.N Engl J Med. 1999;340:508–516.
Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.Science. 2002;296:2410–2413.
Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implication for cell therapy of bone.Proc Natl Acad Sci USA. 2002;99: 8932–8937.
Georges GE, Storb R. Stem cell transplantation for aplastic anemia.Int J Hematol. 2002;75:141–146.
Sullivan KM, Walters MC, Patience M, et al. Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders.Bone Marrow Transplant. 1997;19:102–105.
Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia: the experience of Persaro.Ann NY Acad Sci. 1998;850:270–275.
Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report.Blood. 2000;95:1918–1924.
Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood MarrowTransplant. 2001;7: 665–673.
Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases.J Rheumatol. 1997;48:1–4.
Brodsky RA. High-dose cyclophosphamide for aplastic anemia and autoimmunity.Curr Opin Oncol. 2002;14:143–146.
McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.Blood. in press.
Author information
Authors and Affiliations
About this article
Cite this article
Sullivan, K.M. Bone marrow transplantation for non-malignant disease. Int J Hematol 76 (Suppl 1), 169–170 (2002). https://doi.org/10.1007/BF03165239
Issue Date:
DOI: https://doi.org/10.1007/BF03165239